Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Adagene Inc. (ADAG)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 23
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Adagene Inc. - ADS, each representing 1.25 ordinary shares.

Comment Full text

Adagene Inc. (ADAG)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 21
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

Acurx Pharmaceuticals Inc. (ACXP)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 20
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

Acurx Pharmaceuticals Inc. (ACXP)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 19
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Acurx Pharmaceuticals, Inc. - Common Stock.

Comment Full text

Acasti Pharma Inc. (ACST)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 22
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Acasti Pharma, Inc. - Class A Common Stock.

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 25
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 24
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Adaptimmune Therapeutics plc - American Depositary Shares.

Comment Full text

Acasti Pharma Inc. (ACST)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 24
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 24
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: -. New value: D.

Comment Full text

Acorda Therapeutics Inc. (ACOR)

  • Technical Exchange News
  • Jan. 28, 2024, 23:18 UTC
  • 21
  • 0 comments

NASDAQ traded attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text
  • Previous
  • 1204
  • 1205
  • 1206
  • 1207
  • 1208
  • Next

Search

News categories

  • Technical Exchange News(12372)
  • Event(6229)
  • SEC News(272520)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158357)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin